![](/img/cover-not-exists.png)
Validity Of Patient-Reported Outcomes From Columbus, A Randomized Open Label Phase Iii Clinical Trial Of Encorafenib Plus Binimetinib VS Vemurafenib In Advanced Braf-Mutant Melanoma
Rahhali, N, Chalem, Y, Niemira, J, van Gils, CW, Blome, C, Gerlier, LVolume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.04.318
Date:
May, 2018
File:
PDF, 82 KB
english, 2018